Lidocaine Hydrochloride
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION USP, 2% (Viscous)
Approved
Approval ID
cc1cd1ff-b219-4281-8378-118f4f1beee3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 16, 2021
Manufacturers
FDA
PINNACLE PHARMA LLC
DUNS: 081126970
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lidocaine Hydrochloride
PRODUCT DETAILS
NDC Product Code81646-143
Application NumberANDA040708
Marketing CategoryC73584
Route of AdministrationOROPHARYNGEAL
Effective DateJanuary 28, 2022
Generic NameLidocaine Hydrochloride
INGREDIENTS (8)
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
LIDOCAINE HYDROCHLORIDE ANHYDROUSActive
Quantity: 20 mg in 1 mL
Code: EC2CNF7XFP
Classification: ACTIB